Kuoxin Decoction promotes lymphangiogenesis in zebrafish and in vitro based on network analysis

Background: Inadequate lymphangiogenesis is closely related to the occurrence of many kinds of diseases, and one of the important treatments is to promote lymphangiogenesis. Kuoxin Decoction (KXF) is an herbal formula from traditional Chinese medicine used to treat dilated cardiomyopathy (DCM), whic...

Full description

Bibliographic Details
Main Authors: Longping Peng, Mengjiao Ma, Yidan Dong, Qiong Wu, Shiying An, Min Cao, Yi Wang, Chang Zhou, Maolin Zhou, Xu Wang, Qianqian Liang, Youhua Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.915161/full
_version_ 1811183146726588416
author Longping Peng
Mengjiao Ma
Yidan Dong
Qiong Wu
Shiying An
Min Cao
Yi Wang
Chang Zhou
Maolin Zhou
Xu Wang
Qianqian Liang
Qianqian Liang
Qianqian Liang
Youhua Wang
author_facet Longping Peng
Mengjiao Ma
Yidan Dong
Qiong Wu
Shiying An
Min Cao
Yi Wang
Chang Zhou
Maolin Zhou
Xu Wang
Qianqian Liang
Qianqian Liang
Qianqian Liang
Youhua Wang
author_sort Longping Peng
collection DOAJ
description Background: Inadequate lymphangiogenesis is closely related to the occurrence of many kinds of diseases, and one of the important treatments is to promote lymphangiogenesis. Kuoxin Decoction (KXF) is an herbal formula from traditional Chinese medicine used to treat dilated cardiomyopathy (DCM), which is associated with lymphangiogenesis deficiency. In this study, we comprehensively verified whether KXF promotes lymphangiogenesis in zebrafish and in vitro based on network analysis.Methods: We performed virtual screening of the active compounds of KXF and potential targets regarding DCM based on network analysis. Tg (Flila: EGFP; Gata1: DsRed) transgenic zebrafish embryos were treated with different concentrations of KXF for 48 h with or without the pretreatment of MAZ51 for 6 h, followed by morphological observation of the lymphatic vessels and an assessment of lymphopoiesis. RT-qPCR was employed to identify VEGF-C, VEGF-A, PROX1, and LYVE-1 mRNA expression levels in different groups. After the treatment of lymphatic endothelial cells (LECs) with different concentrations of salvianolic acid B (SAB, the active ingredient of KXF), their proliferation, migration, and protein expression of VEGF-C and VEGFR-3 were compared by CCK-8 assay, wound healing assay, and western blot.Results: A total of 106 active compounds were identified constituting KXF, and 58 target genes of KXF for DCM were identified. There were 132 pathways generated from KEGG enrichment, including 5 signaling pathways related to lymphangiogenesis. Zebrafish experiments confirmed that KXF promoted lymphangiogenesis and increased VEGF-C and VEGF-A mRNA expression levels in zebrafish with or without MAZ51-induced thoracic duct injury. In LECs, SAB promoted proliferation and migration, and it could upregulate the protein expression of VEGF-C and VEGFR-3 in LECs after injury.Conclusion: The results of network analysis showed that KXF could regulate lymphangiogenesis through VEGF-C and VEGF-A, and experiments with zebrafish confirmed that KXF could promote lymphangiogenesis. Cell experiments confirmed that SAB could promote the proliferation and migration of LECs and upregulate the protein expression of VEGF-C and VEGFR-3. These results suggest that KXF promotes lymphangiogenesis by a mechanism related to the upregulation of VEGF-C/VEGFR-3, and the main component exerting this effect may be SAB.
first_indexed 2024-04-11T09:42:55Z
format Article
id doaj.art-37f9f0cb4d5842a99aced58d8ab59534
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-11T09:42:55Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-37f9f0cb4d5842a99aced58d8ab595342022-12-22T04:31:09ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-08-011310.3389/fphar.2022.915161915161Kuoxin Decoction promotes lymphangiogenesis in zebrafish and in vitro based on network analysisLongping Peng0Mengjiao Ma1Yidan Dong2Qiong Wu3Shiying An4Min Cao5Yi Wang6Chang Zhou7Maolin Zhou8Xu Wang9Qianqian Liang10Qianqian Liang11Qianqian Liang12Youhua Wang13Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaShanghai Cancer Center, Fudan University, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSpine Institute, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaKey Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaBackground: Inadequate lymphangiogenesis is closely related to the occurrence of many kinds of diseases, and one of the important treatments is to promote lymphangiogenesis. Kuoxin Decoction (KXF) is an herbal formula from traditional Chinese medicine used to treat dilated cardiomyopathy (DCM), which is associated with lymphangiogenesis deficiency. In this study, we comprehensively verified whether KXF promotes lymphangiogenesis in zebrafish and in vitro based on network analysis.Methods: We performed virtual screening of the active compounds of KXF and potential targets regarding DCM based on network analysis. Tg (Flila: EGFP; Gata1: DsRed) transgenic zebrafish embryos were treated with different concentrations of KXF for 48 h with or without the pretreatment of MAZ51 for 6 h, followed by morphological observation of the lymphatic vessels and an assessment of lymphopoiesis. RT-qPCR was employed to identify VEGF-C, VEGF-A, PROX1, and LYVE-1 mRNA expression levels in different groups. After the treatment of lymphatic endothelial cells (LECs) with different concentrations of salvianolic acid B (SAB, the active ingredient of KXF), their proliferation, migration, and protein expression of VEGF-C and VEGFR-3 were compared by CCK-8 assay, wound healing assay, and western blot.Results: A total of 106 active compounds were identified constituting KXF, and 58 target genes of KXF for DCM were identified. There were 132 pathways generated from KEGG enrichment, including 5 signaling pathways related to lymphangiogenesis. Zebrafish experiments confirmed that KXF promoted lymphangiogenesis and increased VEGF-C and VEGF-A mRNA expression levels in zebrafish with or without MAZ51-induced thoracic duct injury. In LECs, SAB promoted proliferation and migration, and it could upregulate the protein expression of VEGF-C and VEGFR-3 in LECs after injury.Conclusion: The results of network analysis showed that KXF could regulate lymphangiogenesis through VEGF-C and VEGF-A, and experiments with zebrafish confirmed that KXF could promote lymphangiogenesis. Cell experiments confirmed that SAB could promote the proliferation and migration of LECs and upregulate the protein expression of VEGF-C and VEGFR-3. These results suggest that KXF promotes lymphangiogenesis by a mechanism related to the upregulation of VEGF-C/VEGFR-3, and the main component exerting this effect may be SAB.https://www.frontiersin.org/articles/10.3389/fphar.2022.915161/fullKuoxin Decoctionlymphangiogenesiszebrafishlymphatic endothelial cellssalvianolic acid Bnetwork analysis
spellingShingle Longping Peng
Mengjiao Ma
Yidan Dong
Qiong Wu
Shiying An
Min Cao
Yi Wang
Chang Zhou
Maolin Zhou
Xu Wang
Qianqian Liang
Qianqian Liang
Qianqian Liang
Youhua Wang
Kuoxin Decoction promotes lymphangiogenesis in zebrafish and in vitro based on network analysis
Frontiers in Pharmacology
Kuoxin Decoction
lymphangiogenesis
zebrafish
lymphatic endothelial cells
salvianolic acid B
network analysis
title Kuoxin Decoction promotes lymphangiogenesis in zebrafish and in vitro based on network analysis
title_full Kuoxin Decoction promotes lymphangiogenesis in zebrafish and in vitro based on network analysis
title_fullStr Kuoxin Decoction promotes lymphangiogenesis in zebrafish and in vitro based on network analysis
title_full_unstemmed Kuoxin Decoction promotes lymphangiogenesis in zebrafish and in vitro based on network analysis
title_short Kuoxin Decoction promotes lymphangiogenesis in zebrafish and in vitro based on network analysis
title_sort kuoxin decoction promotes lymphangiogenesis in zebrafish and in vitro based on network analysis
topic Kuoxin Decoction
lymphangiogenesis
zebrafish
lymphatic endothelial cells
salvianolic acid B
network analysis
url https://www.frontiersin.org/articles/10.3389/fphar.2022.915161/full
work_keys_str_mv AT longpingpeng kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT mengjiaoma kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT yidandong kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT qiongwu kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT shiyingan kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT mincao kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT yiwang kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT changzhou kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT maolinzhou kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT xuwang kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT qianqianliang kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT qianqianliang kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT qianqianliang kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis
AT youhuawang kuoxindecoctionpromoteslymphangiogenesisinzebrafishandinvitrobasedonnetworkanalysis